However, adjustment for age and gender did not influence the overall difference with higher levels of CTX and osteocalcin in patients with CKD compared to healthy controls, and no difference between groups in the overall level of the other bone turnover markers (data not shown). This evidence concerns the gene BGLAP and chronic kidney disease.